SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Rossari Biotech surges on eyeing 50% growth in FY22

07 Oct 2021 Evaluate

Rossari Biotech is currently trading at Rs. 1499.95, up by 7.95 points or 0.53% from its previous closing of Rs. 1492.00 on the BSE.

The scrip opened at Rs. 1533.95 and has touched a high and low of Rs. 1533.95 and Rs. 1493.75 respectively. So far 2053 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 1591.80 on 15-Sep-2021 and a 52 week low of Rs. 750.00 on 13-Oct-2020.

Last one week high and low of the scrip stood at Rs. 1541.90 and Rs. 1432.65 respectively. The current market cap of the company is Rs. 8249.65 crore.

The promoters holding in the company stood at 68.70%, while Institutions and Non-Institutions held 21.42% and 9.88% respectively.

Rossari Biotech is eyeing to close FY'22 with at least 50 per cent growth in both topline and bottomline on the back of rising demand and a substantial price hike that will help boost margins.

Apart from being the largest textile specialty chemical manufacturer, Rossari is also a leading supplier of specialty chemicals to the animal and poultry feed industry, and FMCG companies and is present in 17 overseas markets like including Bangladesh, Vietnam and Mauritius.

Rossari Biotech is a specialty chemical manufacturing firm with focus on home and personal care, performance chemicals, textile specialty chemicals and animal health and nutrition products. Apart from India, it has operations in 17 countries including Vietnam, Bangladesh and Mauritius.


Rossari Biotech Share Price

480.15 1.40 (0.29%)
04-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3651.95
Tata Chemicals 804.85
SRF 2551.40
Pidilite Inds. 1364.45
Deepak Nitrite 1751.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×